173 related articles for article (PubMed ID: 32662574)
1. Analysis of impurities in pharmaceuticals by LC-MS with cold electron ionization.
Tsizin S; Fialkov AB; Amirav A
J Mass Spectrom; 2020 Oct; 55(10):e4587. PubMed ID: 32662574
[TBL] [Abstract][Full Text] [Related]
2. Electron ionization LC-MS with supersonic molecular beams--the new concept, benefits and applications.
Seemann B; Alon T; Tsizin S; Fialkov AB; Amirav A
J Mass Spectrom; 2015 Nov; 50(11):1252-63. PubMed ID: 26505770
[TBL] [Abstract][Full Text] [Related]
3. Forced degradation and impurity profiling: recent trends in analytical perspectives.
Jain D; Basniwal PK
J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
[TBL] [Abstract][Full Text] [Related]
4. Strategy for identification of leachables in packaged pharmaceutical liquid formulations.
Pan C; Harmon F; Toscano K; Liu F; Vivilecchia R
J Pharm Biomed Anal; 2008 Feb; 46(3):520-7. PubMed ID: 18180126
[TBL] [Abstract][Full Text] [Related]
5. A comparison of electron ionization mass spectra obtained at 70 eV, low electron energies, and with cold EI and their NIST library identification probabilities.
Margolin Eren KJ; Elkabets O; Amirav A
J Mass Spectrom; 2020 Dec; 55(12):e4646. PubMed ID: 32996658
[TBL] [Abstract][Full Text] [Related]
6. Identification of related impurities in an oral pharmaceutical formulation of tebipenem pivoxil using ultra-high-performance liquid chromatography/electrospray ionization quadrupole time-of-flight tandem mass spectrometry.
Xi P; Cao W; Li L; Shi W; Li F; Xu H; Xu X; Ke Y; Zhang J
Rapid Commun Mass Spectrom; 2021 Aug; 35(16):e9129. PubMed ID: 34097785
[TBL] [Abstract][Full Text] [Related]
7. Classical electron ionization mass spectra in gas chromatography/mass spectrometry with supersonic molecular beams.
Gordin A; Fialkov AB; Amirav A
Rapid Commun Mass Spectrom; 2008 Sep; 22(17):2660-6. PubMed ID: 18666200
[TBL] [Abstract][Full Text] [Related]
8. Combining linear retention index and electron ionization mass spectrometry for a reliable identification in nano liquid chromatography.
Rigano F; Russo M; Arigò A; Dugo P; Mondello L
J Chromatogr A; 2020 Jan; 1610():460581. PubMed ID: 31610919
[TBL] [Abstract][Full Text] [Related]
9. NanoLC-EI-MS: Perspectives in Biochemical Analysis.
Pereira Dos Santos NG; Maciel EVS; Vargas Medina DA; Lanças FM
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511506
[TBL] [Abstract][Full Text] [Related]
10. How enhanced molecular ions in Cold EI improve compound identification by the NIST library.
Alon T; Amirav A
Rapid Commun Mass Spectrom; 2015 Dec; 29(23):2287-92. PubMed ID: 26522322
[TBL] [Abstract][Full Text] [Related]
11. Pesticide analysis by pulsed flow modulation GCxGC-MS with Cold EI-an alternative to GC-MS-MS.
Keshet U; Goldshlag P; Amirav A
Anal Bioanal Chem; 2018 Sep; 410(22):5507-5519. PubMed ID: 29236133
[TBL] [Abstract][Full Text] [Related]
12. Identification, characterization and quantification of new impurities by LC-ESI/MS/MS and LC-UV methods in rivastigmine tartrate active pharmaceutical ingredient.
Thomas S; Shandilya S; Bharati A; Paul SK; Agarwal A; Mathela CS
J Pharm Biomed Anal; 2012 Jan; 57():39-51. PubMed ID: 21880452
[TBL] [Abstract][Full Text] [Related]
13. Identification of impurities in polymyxin B and colistin bulk sample using liquid chromatography coupled to mass spectrometry.
Van den Bossche L; Van Schepdael A; Chopra S; Hoogmartens J; Adams E
Talanta; 2011 Feb; 83(5):1521-9. PubMed ID: 21238747
[TBL] [Abstract][Full Text] [Related]
14. Soft Cold EI - approaching molecular ion only with electron ionization.
Amirav A; Keshet U; Danon A
Rapid Commun Mass Spectrom; 2015 Nov; 29(21):1954-60. PubMed ID: 26443393
[TBL] [Abstract][Full Text] [Related]
15. Normal phase and reverse phase HPLC-UV-MS analysis of process impurities for rapamycin analog ABT-578: application to active pharmaceutical ingredient process development.
Chen Y; Brill GM; Benz NJ; Leanna MR; Dhaon MK; Rasmussen M; Zhou CC; Bruzek JA; Bellettini JR
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Oct; 858(1-2):106-17. PubMed ID: 17826364
[TBL] [Abstract][Full Text] [Related]
16. Highly efficient, selective, sensitive and stability indicating RP-HPLC-UV method for the quantitative determination of potential impurities and characterization of four novel impurities in eslicarbazepine acetate active pharmaceutical ingredient by LC/ESI-IT/MS/MS.
Thomas S; Bharti A; Maddhesia PK; Shandilya S; Agarwal A; Dharamvir ; Biswas S; Bhansal V; Gupta AK; Tewari PK; Mathela CS
J Pharm Biomed Anal; 2012 Mar; 61():165-75. PubMed ID: 22178334
[TBL] [Abstract][Full Text] [Related]
17. Gas chromatography-mass spectrometry with supersonic molecular beams.
Amirav A; Gordin A; Poliak M; Fialkov AB
J Mass Spectrom; 2008 Feb; 43(2):141-63. PubMed ID: 18225851
[TBL] [Abstract][Full Text] [Related]
18. Electron Ionization Mass Spectrometry for Both Liquid and Gas Chromatography in One System without the Need for Hardware Adjustments.
Tsizin S; Fialkov AB; Amirav A
J Am Soc Mass Spectrom; 2020 Jun; ():. PubMed ID: 32543199
[TBL] [Abstract][Full Text] [Related]
19. Targeted and untargeted screening for impurities in losartan tablets marketed in Germany by means of liquid chromatography/high resolution mass spectrometry.
Backer L; Kinzig M; Sörgel F; Scherf-Clavel O; Holzgrabe U
J Pharm Biomed Anal; 2024 Aug; 245():116160. PubMed ID: 38663256
[TBL] [Abstract][Full Text] [Related]
20. LC-MS characterization of trace impurities contained in calcium folinate.
Francese G; Corana F; Meneghetti O; Marazza F
J Pharm Biomed Anal; 2005 Sep; 39(3-4):757-63. PubMed ID: 15927438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
